1[1]Intemational Union Against Cancer: TNM Classification of Malignant Tumors. 4th ed, Berlin: Springer-Verlag, 1987:69 ～ 73.
2[2]Intemational Union Against Cancer: TNM Classification of Malignant Tumors, 5th ed, New York: Wiley-Liss, 1997: 93～100
3[3]Ginsberg RJ. Continuing controversies in staging NSCLC:an analysis of the revised 1997 staging system. Oncology (huntingt. 1998: 12(1)supp1: 51～54
4[4]Leoig SS. Rocha Lima CM, Sherman CA,et al. The 1997 International Staging System for non-small cell lung cancer:have all the issues been addressed? Chest, 1999, 115(1): 241～248
5[5]Van Velzen E. Snijder RJ. Brutel de la Riviere A, et al.Lymph node type as a prognostic factor for survival in T2N1M0 non-small cell lung carcinoma. Ann Thorac Surg,1997, 63(5): 1436～1440
6[6]Martini N, Bains Ms, Burt ME, et al. Incidence of local recurrence and second primary tumors in resectcd stage I lung cancerJ Thorac Cardiovasc Surg. 1995. 109(1): 120～129
7[7]Lee JD, Ginsberg RJ. Lung cancer staging: the value of ipsilateral scalene 1vmph node biopsy performed at medi astinoscopy. Ann Thorac Surg, 1996, 62(2): 338～341
8[8]Naruke T. Mediastinal lymph node dissection. In Pearson FG.Deslauriers J. Ginsberg RJ, et al. (eds): Thorac Surg. New York: Churchill Livingstone, 1995:909～917
9[9]Wronski M, Arbit E. Burt M. el al. Survival after surgical treatment of brain metastases from lung cancer: a follow up study of 231 patients treated between 1976 and 1991. J Neu rosurg, 1995, 83(4): 605～616
10[10]American Thoracic Society: Clinical staging of primary lung cancer. Ann Rev Respir Dis, 1983: 27:1～6
2Cangir AK, Akal M, Gungor A, et al. Prognostic value of tumor size in non-small cell lung cancer than five centimeters in diameter. Lung Cancer, 2004, 46:325-331.
3Hosokawa Y, Matsuge S, Murakami Y, et al. Validity and controversies in the new postoperative pathologic TNM classification based on the results of surgical treatment of non-small cell lung cancer. Kyobu Geka, 2000, 53:910-914.
4Stolz A j, Pipkova R, Schutzner J, et al. Computer tomography and staging of bronchogenic carcinoma, prospective study. Cas Lek Cesk, 2004, 143:752-755.
